Credit Suisse Ag Amgen Inc Call Options Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $1.67 Million - $1.91 Million	-8,400 Reduced 9.21%	82,800 $18.6 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $7.24 Million - $8.48 Million	34,100 Added 59.72%	91,200 $19.4 Million
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $5.21 Million - $5.78 Million	-22,300 Reduced 28.09%	57,100 $13.9 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $1.58 Million - $1.84 Million	-7,100 Reduced 8.21%	79,400 $19.8 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $3.53 Million - $4.2 Million	-16,300 Reduced 15.86%	86,500 $19.9 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $8.56 Million - $9.52 Million	36,500 Added 55.05%	102,800 $26.1 Million
Q2 2020 Aug 12, 2020	SELL	$197.81 - $242.74 $573,649 - $703,946	-2,900 Reduced 4.19%	66,300 $15.6 Million
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $4.37 Million - $5.8 Million	-24,000 Reduced 25.75%	69,200 $14 Million
Q4 2019 Feb 12, 2020	BUY	$189.21 - $243.2 $12.8 Million - $16.4 Million	67,500 Added 262.65%	93,200 $22.5 Million
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $2.59 Million - $3.11 Million	-14,900 Reduced 36.7%	25,700 $4.97 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $5.03 Million - $5.9 Million	-30,200 Reduced 42.66%	40,600 $7.48 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $14.5 Million - $16.3 Million	-80,000 Reduced 53.05%	70,800 $13.5 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $19.8 Million - $23.1 Million	110,800 Added 277.0%	150,800 $29.4 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $37,058 - $41,778	-200 Reduced 0.5%	40,000 $8.29 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $19.9 Million - $22.4 Million	-120,000 Reduced 74.91%	40,200 $7.42 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $3.35 Million - $3.92 Million	-19,800 Reduced 11.0%	160,200 $27.3 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $6.04 Million - $6.75 Million	-35,800 Reduced 16.59%	180,000 $31.3 Million
Q3 2017 Nov 14, 2017	SELL	$167.29 - $191.0 $6.49 Million - $7.41 Million	-38,800 Reduced 15.24%	215,800 $40.2 Million
Q2 2017 Aug 14, 2017	BUY	N/A	254,600	254,600 $43.9 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account